Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.

By Douglas G. Altman, G. Carroli, L. Duley, B. Farrell, J. Moodley, J. Neilson, David Smith. The Lancet, 2002

1,358 citations recorded by the source corpus.

Subfields: Epidemiology, Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/5a232d6412a159458b6ae4979beb85810874dae7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. David Moher

Citations in the corpus

• The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. (2021, background): “There is clear evidence that magnesium sulphate halves both the incidence and recurrence of eclampsia [167 – 168].”
• Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. (2013, methodology): “[61] Altman D, Carroli G, Duley L, et al.”